It was higher (21%) in patients with hepatocellular carcinoma (HCC) and in patients with high aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (39%).5, 9, 10. The gene discussed is GPT; the disease is hepatocellular carcinoma.